Clinical Trial Update: Prospective Evaluation of Open-Angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two iStents [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating open-angle glaucoma patients treated with two iStents in addition to a topical hypotensive medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• iStent

Snippet

Sponsor: Glaukos Corporation | Conditions: Subjects With Primary Open-angle Glaucoma (POAG) | Phase 4 | Status: COMPLETED